tDCS for Multiple System Atrophy With Cerebellar Feature

Inclusion Criteria: * 1\. Patients who meet the clinical criteria for probable multiple system atrophy with cerebellar features (MDS second consensus statement on the diagnosis of multiple system atrophy) * 2\. Patients aged between 40 and 70 * 3\. Patients who do not have rigidity and bradykinesia * 4\. Patients who have given voluntary consent after understanding the content of the clinical trial Exclusion Criteria: * 1\. Patients with a serious cognitive disorder, behavioral disorder, or mental illness * 2\. Patients have history of seizure, stroke, encephalitis, other degenerative neurological disease * 3\. Patients with a serious medical disease * Patients who concomitantly suffer from severe renal impairment, convulsions, stomach ulcers, moderate or more severe liver disease * Patients with un-controlled high blood pressure or diabetes * 4\. Patients who have taken another investigational products within 4 weeks prior to being enrolled in this clinical trial, or patients who are pregnant or breastfeeding